当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析

川宁生物

(301301)

  

流通市值:74.34亿  总市值:268.82亿
流通股本:6.16亿   总股本:22.27亿

川宁生物(301301)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润10.76亿元,每股收益0.48元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益758921.12万元,未分配利润188952.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1055137.65万元,负债296216.53万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入4,456,265,553.383,195,426,670.391,523,218,1644,823,335,006.68
营业总成本3,154,494,351.32,264,062,909.631,098,639,822.393,648,830,039.14
营业利润1,294,715,549.77919,680,528.83423,227,4991,121,399,685.69
利润总额1,277,922,127.14909,157,129.09421,919,620.051,117,711,071.63
净利润1,075,957,079.13766,327,623.76352,626,111.92940,564,996.29
其他综合收益--0-
综合收益总额1,075,957,079.13766,327,623.76352,626,111.92940,564,996.29
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计4,088,077,855.644,080,156,983.024,368,764,730.583,956,435,233.94
非流动资产合计6,463,298,638.296,519,008,097.566,205,103,894.376,182,213,893.61
资产总计10,551,376,493.9310,599,165,080.5810,573,868,624.9510,138,649,127.55
流动负债合计1,996,994,497.662,122,261,813.742,480,186,224.482,535,717,317.94
非流动负债合计965,170,787.41,206,163,345.86760,468,671.75629,576,296.56
负债合计2,962,165,285.063,328,425,159.63,240,654,896.233,165,293,614.5
归属于母公司股东权益合计7,570,369,941.777,257,844,675.937,320,330,771.436,960,483,793.26
股东权益合计7,589,211,208.877,270,739,920.987,333,213,728.726,973,355,513.05
负债和股东权益合计10,551,376,493.9310,599,165,080.5810,573,868,624.9510,138,649,127.55
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,165,660,715.722,211,561,298.13792,326,034.254,186,265,791.76
经营活动现金流出小计2,290,401,046.281,439,134,827.5521,756,662.122,893,876,830.91
经营活动产生的现金流量净额875,259,669.44772,426,470.63270,569,372.131,292,388,960.85
投资活动现金流入小计201,145,426.03246,200107,300201,887,735.3
投资活动现金流出小计312,628,060.1370,411,589.8180,063,954.6555,260,201.05
投资活动产生的现金流量净额-111,482,634.1-70,165,389.81-79,956,654.6-353,372,465.75
筹资活动现金流入小计716,191,920340,260,920150,000,000858,669,000
筹资活动现金流出小计1,620,322,311.82886,771,986.03216,575,155.572,667,130,334.91
筹资活动产生的现金流量净额-904,130,391.82-546,511,066.03-66,575,155.57-1,808,461,334.91
汇率变动对现金及现金等价物的影响1,255,140.022,995,954.971,071,293.013,334,042.02
现金及现金等价物净增加额-139,098,216.46158,745,969.76125,108,854.97-866,110,797.79
期末现金及现金等价物余额618,915,346.89916,759,533.11883,122,418.32758,013,563.35
最新报告期:2024-11-12
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
山西证券魏赟0.630.740.832024-11-12
TOP↑